Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection

NCT01119105 is registered in ClinicalTrials.gov with Nabriva Therapeutics AG as lead sponsor.

NCT NCT01119105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01119105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Lead sponsor
Nabriva Therapeutics AG
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
February 3, 2011
Enrollment
210 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, infection